Research Publications

The Pharmacodynamics of Switching Between P2Y12 Receptor Antagonists.

Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial.

Cardiovascular Interventions in the Modern Age: The Million Dollar Man.

Clinical Implications of Leaks Following Left Atrial Appendage Ligation With the LARIAT Device.

The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX.

PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.

Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial.

Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) Trial.

Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.

Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study.